The Assurance Nasal Alar Sp02 sensor applied to the nasal ala detects Sp02 changes faster than finger applied sensors, an early response that can be critical for clinical intervention in the OR. In research studies, Nasal Alar Oximetry detected desaturations up to 30 seconds faster than finger applied sensors. Additionally, in a recent study, the nasal alar sensor was validated for 7 days of continuous use. This can reduce costs as the sensor can move with the patient from the OR to hospital floor. Lastly, it will work with most hospital's existing monitoring so no capital investment is needed to start using the Alar sensor on your difficult to monitor patients.